Maternal anti-SSA and anti-SSB antibodies can pass through the placenta during pregnancy and affect the fetal heart, resulting in structural or rhythmic abnormalities, such as atrioventricular block, EFE, sinus bradycardia, and delayed dilated cardiomyopathy (4). This evidence concerns the gene CALR and atrioventricular block.